Touchstone International Medical Science Co., Ltd.
SSE:688013.SS
26.88 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 65.846 | 70.282 | 69.352 | 72.514 | 60.22 | 83.746 | 54.208 | 68.02 | 59.472 | 63.764 | 62.133 | 55.502 | 50.635 | 60.864 | 53.71 | 53.33 | 45.833 | 44.51 | 48.692 | 39.598 | 30.544 | 41.763 | 49.581 | 47.53 | 33.884 |
| Cost of Revenue
| 27.352 | 28.596 | 28.767 | 30.736 | 24.968 | 33.001 | 24.37 | 27.783 | 26.213 | 32.511 | 24.953 | 21.438 | 20.211 | 25.341 | 24.018 | 22.707 | 18.827 | 19.644 | 19.503 | 16.457 | 12.472 | 16.333 | 19.758 | 18.929 | 14.005 |
| Gross Profit
| 38.494 | 41.686 | 40.585 | 41.778 | 35.252 | 50.744 | 29.838 | 40.237 | 33.259 | 31.252 | 37.18 | 34.063 | 30.424 | 35.523 | 29.692 | 30.623 | 27.006 | 24.866 | 29.189 | 23.141 | 18.073 | 25.429 | 29.823 | 28.601 | 19.878 |
| Gross Profit Ratio
| 0.585 | 0.593 | 0.585 | 0.576 | 0.585 | 0.606 | 0.55 | 0.592 | 0.559 | 0.49 | 0.598 | 0.614 | 0.601 | 0.584 | 0.553 | 0.574 | 0.589 | 0.559 | 0.599 | 0.584 | 0.592 | 0.609 | 0.602 | 0.602 | 0.587 |
| Reseach & Development Expenses
| 8.772 | 11.258 | 9.162 | 8.474 | 7.099 | 10.634 | 7.981 | 8.751 | 7.954 | 9.665 | 8.616 | 7.665 | 8.802 | 9.621 | 7.873 | 8.006 | 3.775 | 5.258 | 3.924 | 2.915 | 3.273 | 4.288 | 3.417 | 3.199 | 3.199 |
| General & Administrative Expenses
| 8.952 | -9.286 | 18.216 | -1.529 | 7.58 | -9.908 | 15.398 | -0.514 | 7.732 | -7.385 | 14.287 | 0.04 | 6.133 | -5.838 | 12.759 | -0.028 | 3.703 | -6.526 | 6.539 | 4.884 | 3.8 | -4.882 | 2.414 | 3.075 | 3.075 |
| Selling & Marketing Expenses
| 10.646 | -6.327 | 18.016 | 8.854 | 9.008 | 13.463 | 9.792 | 10.415 | 7.938 | 11.255 | 7.888 | 6.489 | 7.286 | 13.155 | 7.837 | 8.245 | 7.652 | 9.56 | 7.549 | 6.025 | 5.242 | 9.287 | 9.615 | 5.872 | 5.872 |
| SG&A
| 19.598 | -15.613 | 36.397 | 7.324 | 16.589 | 3.555 | 25.19 | 9.902 | 15.67 | 3.87 | 22.175 | 6.529 | 13.419 | 7.317 | 20.596 | 8.217 | 11.356 | 3.033 | 14.088 | 10.891 | 9.108 | 4.405 | 12.03 | 9.195 | 9.195 |
| Other Expenses
| -4.433 | 37.136 | -19.93 | 0.205 | -0.135 | -64.193 | 0.029 | 0.493 | 0.505 | 16.559 | -6.312 | 7.257 | 0.499 | -0.08 | -0.042 | 1.472 | -0.141 | 2.11 | 0.348 | -13.597 | -12.418 | 0.934 | 1.247 | -13.6 | -11.479 |
| Operating Expenses
| 23.937 | 32.781 | 25.629 | 25.716 | 23.919 | 64.193 | 24.689 | 28.247 | 24.129 | 30.094 | 24.479 | 21.45 | 22.72 | 32.501 | 22.842 | 22.899 | 15.488 | 19.792 | 18.382 | -13.597 | -12.418 | 18.679 | 16.03 | -13.6 | -11.479 |
| Operating Income
| 14.557 | 8.905 | 14.956 | 18.64 | 12.496 | 19.553 | 7.068 | 15.926 | 12.463 | 8.856 | 15.179 | 9.272 | 7.205 | 6.495 | 11.193 | 12.589 | 14.605 | 8.011 | 11.143 | 9.544 | 5.654 | 7.605 | 14.144 | 15.001 | 8.4 |
| Operating Income Ratio
| 0.221 | 0.127 | 0.216 | 0.257 | 0.208 | 0.233 | 0.13 | 0.234 | 0.21 | 0.139 | 0.244 | 0.167 | 0.142 | 0.107 | 0.208 | 0.236 | 0.319 | 0.18 | 0.229 | 0.241 | 0.185 | 0.182 | 0.285 | 0.316 | 0.248 |
| Total Other Income Expenses Net
| 0.001 | -0.295 | 0.059 | 0.205 | -0.135 | 1.032 | 0.029 | 0.493 | -0.041 | 0.635 | 0.08 | 0.05 | 1.201 | -0.08 | -0.042 | 1.472 | -0.141 | 2.11 | 0.348 | 2.288 | 1.103 | 0.934 | 1.247 | 0.719 | 0.548 |
| Income Before Tax
| 14.558 | 8.611 | 15.015 | 18.844 | 12.361 | 20.716 | 7.097 | 16.419 | 12.422 | 9.491 | 15.259 | 12.926 | 8.407 | 6.416 | 11.151 | 14.061 | 14.465 | 10.121 | 11.491 | 11.832 | 6.757 | 8.539 | 15.391 | 15.72 | 8.948 |
| Income Before Tax Ratio
| 0.221 | 0.123 | 0.217 | 0.26 | 0.205 | 0.247 | 0.131 | 0.241 | 0.209 | 0.149 | 0.246 | 0.233 | 0.166 | 0.105 | 0.208 | 0.264 | 0.316 | 0.227 | 0.236 | 0.299 | 0.221 | 0.204 | 0.31 | 0.331 | 0.264 |
| Income Tax Expense
| 1.372 | -0.533 | 1.115 | 1.345 | 1.009 | 1.168 | 0.575 | 1.529 | 0.723 | -1.912 | 2.59 | 1.071 | 1.138 | 1.346 | -0.334 | 2.136 | 1.525 | 1.245 | 1.71 | 15.137 | -11.669 | 1.141 | 2.253 | 12.827 | -9.63 |
| Net Income
| 13.187 | 9.143 | 13.9 | 17.499 | 11.352 | 19.549 | 6.522 | 14.89 | 11.7 | 11.403 | 12.669 | 11.855 | 7.268 | 5.07 | 11.485 | 11.925 | 12.94 | 8.876 | 9.781 | 10.283 | 6.008 | 7.397 | 13.138 | 14.372 | 7.099 |
| Net Income Ratio
| 0.2 | 0.13 | 0.2 | 0.241 | 0.189 | 0.233 | 0.12 | 0.219 | 0.197 | 0.179 | 0.204 | 0.214 | 0.144 | 0.083 | 0.214 | 0.224 | 0.282 | 0.199 | 0.201 | 0.26 | 0.197 | 0.177 | 0.265 | 0.302 | 0.21 |
| EPS
| 0.17 | 0.116 | 0.18 | 0.22 | 0.14 | 0.24 | 0.082 | 0.19 | 0.15 | 0.15 | 0.16 | 0.15 | 0.091 | 0.063 | 0.14 | 0.15 | 0.16 | 0.15 | 0.16 | 0.17 | 0.1 | 0.12 | 0.22 | 0.24 | 0.12 |
| EPS Diluted
| 0.16 | 0.112 | 0.18 | 0.22 | 0.14 | 0.24 | 0.07 | 0.19 | 0.14 | 0.15 | 0.16 | 0.15 | 0.09 | 0.056 | 0.14 | 0.15 | 0.16 | 0.15 | 0.16 | 0.17 | 0.1 | 0.12 | 0.22 | 0.24 | 0.12 |
| EBITDA
| 14.594 | 7.424 | 16.386 | 17.274 | 14.93 | 14.259 | 9.354 | 19.133 | 15.12 | 12.009 | 17.648 | 14.769 | 8.413 | 8.227 | 12.963 | 8.388 | 16.272 | 10.121 | 12.048 | -4.044 | 6.757 | 8.467 | 15.571 | 12.38 | 19.878 |
| EBITDA Ratio
| 0.222 | 0.106 | 0.236 | 0.238 | 0.248 | 0.17 | 0.173 | 0.281 | 0.254 | 0.188 | 0.284 | 0.266 | 0.166 | 0.135 | 0.241 | 0.157 | 0.355 | 0.227 | 0.247 | -0.102 | 0.221 | 0.203 | 0.314 | 0.26 | 0.587 |